Trial Profile
The comparison of the hypoglycemic effect between insulin glargin U-300 and insulin glargin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Jun 2018 Results published in the Diabetes Therapy Journal.
- 17 Oct 2017 New trial record